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"/.Chloro-4-nitro.benzofurat.an sg,ecticely modif~'s one PPa~ Tyr r~,,idu= i~r subunit and Iow¢~ the e~ym¢ activity, Hydrolyds of the modified 
protein by trypsin and then by chymotrypsin produces the 82-89 pcptide which pcr ,~ modified Tyr.89. $abstratc analog (carP,) and the product 
of the enzyme reaction, MgP,, protect he ¢nzTm¢ allainst inactivation, tons of m¢lal-a¢tit~tors (MR:'. Zn;') exert no influen¢~ on the in=etiwation 
rate. On tlzc contrary, the Ca;'.inhibitor of the enzyme a¢c¢lerat~ the reaction by binding to the high.affinity site, and effectively decreases it when 
Ca:" binds to both sites. MI"" competes with Ca:" for one binding site, wl;ich is the low affinity site for MI~:" and the hillh-al'nnity site for Ca:'. 
Tit,: Ca"" saturation of the high,affinity site decreases the pA'; of Tyr-t~9, probably duc to direct coordination between Tyr and Ca:', The ob~rved 
properties of Tyr.lt9 modifi~tion enable us to propo= that Tyr.t~9 ,=erv~ as a proton donor for phosphate rel~sing during enzymatic hydrolysis 
of pyrophosphat¢, The Ca:" inltibitory effect on the enzyme activity may b= due to the existenc¢ of a Tyr-89 bond in the Ca"' pyrophosphntar¢ 
complex. 
lnorlvmic pyrophosphata~: Chemical modifi=ttion: Esr~ntial i roups; Mc z" affinity; S. c¢revisl=e 
1. INTRODUCTION 
Nowadays chemical modification remains the most 
appropriate method to determine ssential amino acids 
of S. ceret'i~'iae inorganic pyrophosphatas¢ and to eluci- 
date their roles in the active site. The enzyme catalyzes 
hydrolysis of inorganic pyrophosphate in the presen~ 
of" divalent metal ions. A catalytically active complex 
maintains a pyrophosphate molecule and three metal 
ions. two of which bind to the enzyme before PP~ addi- 
tion. MR"" and Zn =" are the most effective activators, 
whereas Ca:" inhibits th¢ enzyme activity. The amino 
acid s¢qt£¢nc¢ and three-dimensional structur= have 
been described, 
The chemical modification method has allowed to 
reveal that Are [l], Glu [2], and Lys [3] residues parti- 
cipate in the substrate catalytic conversion. Pyro- 
phosphatas¢ contains eleven Tyr residues, three of them 
arc located in the active site [4]. It is important hat the 
residues are invariant for all pyrophosphatas~ with 
known amino acid sequences [5,6]. However, the role of 
Tyr residues in the catalysis is still obscure. 
In the present work the modification ofa Tyr residue 
in S, cerevi+~'iae inorganic pyrophoephatase (PPase) by 
7-chloro..4-nitrobenzofurazane wasstudied. Also the in. 
fluence of the substrat¢, enzyme r=action product, 
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metal-activator and metal-inhibitor on this modifica- 
tion was investigated. 
2. MATERIALS AND METHODS 
Inorganic pyrophosphata~ with a sp~[li¢ activity ot" 700 lU/mg 
was isol;Re.d from S, cerevlsiae [?], The enzymatic activiw was assayed 
as in ["), 
7.Chloro-4.nitrot:mnzofarazan wasoblainP.d l'rom 5+rva, Gcn~any; 
acetonitrilc from Merck. Germany; PP+, p-mercaptoethanoL trypsin 
from Sigma. USA: triethanolamin¢. CaCI=, MBCI,, MnCI;, Zn$O+, 
KH:PO4, EGTA from Fluka. Swhz=dand, All other chcmi~ls and 
biochemicals were home.produc¢d. 
The reaction of 0.25 mM Prams with I-S mM b¢nzofurazan, all,t- 
solved in acetone, was carried out in 50 mM tri¢thano[aminc buffer 
pH 8.0 ut 22"C. In the protection experiment, I mM CaCI; and 0,5 
mM PP~ w¢r¢ added to enzyme solution before beltZOfural.an. At 
various times, aliquot., wmr¢ picked out and assayed for PPa~ activity. 
In rome e.xfa:riments ile re.action mixture contained either CaCl.,, 
MgCI_.. MnCl=, ZnSO., or simultaneously CaCI~ and MgCi=. CaCh and 
ZnSO4, M nCI. and K H.,PO4. or EGTA. The control experiments were 
performed without bcnzofurazane, The apparent rate constants were 
calculated from tile dependence ofln(CJC)on time. where Cwas the 
residual activity, 
To obtain modified peptides. 0,36 mM PPa,,e was t rented for 20 sin 
with 3 mM reagent dissolved in acetone. The modified enzyme was 
separated from the rcasent cx=ss and redutcd by dithionitc [9], Tile 
cysteinyl r~idues of tile modified enzyme were pyridyl~thylated with 
4.vin)'lpyridin¢ [10]. Enzymatic l=vaBc with trypsin was carried out 
at 37'C for 12 h in 0.1 M ammonium biearbonat= at the =nzyme to 
S-pyHdylethyiated protein ratio l:100 (w/w), Th= digestion of the 
p¢ptid¢ with chymotrypsin was carried out at the enzyme to pcptide 
ratio 1:50 (wlw), Peptidcs of enzymatic digests wcr¢ fractionated by 
high-performan~ liquid chromatography on Ultrasphcre O¢~,yl 4.6 x 
255 mm with a gradient of 0-60% a~tonitriic n 0,1% trifluoroac~ti¢ 
~cid over 60 sin at the flow rate 0,7 ml/min. Th= pcptides wet= 
visuatizcd by measuring the: absorban~ at 214, 254 and 36.~ am, 
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Th¢ N.|¢m~inttl f~quenc~ ofti~¢ ~ptidcs wtr¢ d¢termincd by auto. 
marie Ednmn d¢|radation using, an Appli¢d Biosyslem (USA) model 
470A/120A scqu¢nccr. 
The pcptid¢/if, va l~ assay was carried out o;~ raai, s spcctrorr~ter 
MX330] (Russia. Sat PetcrburlD, Ionization was pcrforraed by extra¢. 
zion of soluble ion~ at atrnosphcrk: prcxsur¢, 
3. RESULTS AND DISCUSSION 
The treatment of PPa~ with 7-ch|oro-4-nitrobcn- 
zofurazan lead= to inactivation with simultaneous in- 
corporation of the reagent into the enzyme. The proc- 
esses are rather apid and, for example, in the presence 
of 5 mM reagent the enzyme loses 90% of its activity in 
13 man. Protection against he k,tactivation o~urred 
upon the addition of CaPP~. 
It is known that benzofarazan can modify Tyr, Cys. 
Lys prot¢in residues [11]. Derivatives of Tyr and Cys are 
iabell¢d and their treatment with SH.compounds regen- 
erates amino acids. The evidence tbr PPas¢ tyrosin¢ 
modification is based on two experimental facts. First. 
th= inactive nzyme rccov¢rs its activity after p-mercap- 
toethanol action. Secondly, PPase, with its cysteine res- 
idues completely blocked by HgCI., [12], reacts with 
benzofurazan with the same rate as the native one. 
To localize modified Tyr in the amino acid sequence, 
the inactive protein was digcste.,d with trypsin. Only one 
peptide with the bound reagent was registered after hy- 
drolysate separation. It was absent in the case of PPase 
modification i  the pr¢sen~ of CaPP;. The high absorp 
lion of the modified peptide at 254 nm supported the 
presence of a Trp residue. Th¢ amino acid sequence of 
PPas¢ contain=d six Trp residues, which were !ocalizcd 
in six trypti¢ peptidts (Fig. 1). After modification, one 
of them, containing the reagent, changed its time reten- 
tion. As dedu~d from the primary structure, onty one 
peptide of" tryptic digestion has both Trp and Tyr resi- 
dues, This peptide spans from Ash-82 to Lys-lll: 
AsnCysPhcProHisHisGlyTyrlleHisAsnTyrGlyAlaPhe- 
ProGlnThrTrpGluAspProAsnOluSerHisProGluThr- 
Lys. 
The p¢ptide structure was confirmed by molecular 
mass assay and N-terminal sequence analysis. Two Tyr 
residues (Tyr-89 and Tyr-93) were observed in the pep- 
tide. But it was difficult to choose between them since 
tyrosine derivatives were not stable under N.terminal 
sequences determination [9]. Therefore peptid¢ 82-11 i
was hydroly~d by chymotrypsin, resulting in a modi- 
fied new pcptide 82-89, containing only one Tyr-89. 
separated anti its structure proved by the sequence and 
M, value assay using the mass-spectrometry method. 
Thus, we have shown that Tyr-fl9 is an essential residue 
of PPase, Addition of Mg m* or Ca"" to the r=action 
mixture during modification did not change the pcptide 
composition. 
Investigation ofthe effects ofpH, P, metal-activators 
and metal-inhibitor n the reaction of PPase with bcn- 
zofurazane has revealed some interesting fcatur¢s. The 
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Fis. 1, Peptidc separation after tryptic diilcstion, PPatm mo.Jiticd with. 
out addition of CaPP, (a}, in th~ presence of CaPPi (b), 
valu~ of the apparent rate constant are summari~d in
Table I. 
(i) The ionic activators (MB:*, Zn=') did not protect 
the enzyme under the conditions of either low or high 
concentration (Exp. 2, 3, 10 and 11). ProtecLion was 
obs¢rved only with Mn-'" which is the weakest activator 
of the enzyme. The opposite ff~t was found in the 
prcscn~ of Ca='. At a low concentration f Ca:" daring 
its binding to th¢ high-affinity sit,:, the inactivation rate 
clearly increased (Exp. 4). Increasing the Ca:" level led 
to tile saturation of the second binding site and at the 
same time decreased the inactivation rate, which be- 
Table I 
PPas¢ inactivation by ?<hloro.4-nitrobcazofura~an in thepreface of 
metal ions 
Exp, Composition l:.~, Exp. Composition A,.~, 
no. of reaction (man") no. of r¢agtion (rain") 
mixture ra{xlur¢ 
i. I ram reagent 5 raM rc, qIcm 
20 raM EGTA 0,038 9. 20 mM EGTA 0.172 
2, 50 raM MgCI., O,03t; 10. 2 raM MgCl, O, iT2 
3, 20 raM ZnCl= 0,0;18 t l. 2 ram ZnCI: 0.172 
4. 5 raM CaCi= 0,086 12. i00 mM MnCI:, 
2raM rc, lBcnt 13, 1 raM P, ,¢0.017 
5, 20 raM EG'rA 0,073 14. 100 raM MnCI., 0,045 
6, $ mM CaCl:, S raM MgCI.., <¢0.017 
50 raMMgCI. 0,1"/2 15, 25roMP, 
7, 5 mM CaCI:, I rnM CaCI: 0.03t~ 
20 ram ZnCI: 0,1"/2 16, I raM C.aCl: 
8, 5 ram CaCl:. 0,5 raM PP, <¢0.005 
500 raM MgCI: 0,0~0 
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Fill. 2. Del~ndence of the ntto constant of PP~se inactivation on pH 
in the prc~cncc el 5 mM CaCI.. (o) and witllout Ca:" (e). 
came lower than that for the hole.enzyme (compare 
Exp, 9 and l S), The experiments where the Ca"" concen- 
tration was varied in the range of 1-2 mM allowed for 
the calculation of the dissociation constants of 5 mM 
and 500 raM. which were approximately the same as 
cited in the literature [13,14]. 
The Ca" effect did not disappear in the reaction mix- 
ture. containing MgCI: in a concentration sufficient lbr 
saturation of its high-affinity site (Exp. 6). The same 
was valid for Zn-'* (Exp. 7). It means that neither M8:" 
nor Zn '~" compete with Ca"" at the high-affinity site. and 
that these sites are different. At the same time. the 
growth of Mg"" concentration a d its binding at the low 
affinity site blocked the Ca"" effect (Exp, 8), This ena- 
bles us to affirm that Ca "~* and Mg:" (Zn"') have only 
one common binding site, for Ca'" it is the site of high- 
affinity and of low affinity for Mg"" or Zn:'. 
(ii) The Ca:" saturation of the high.affinity site de- 
creases the pK. of the Tyr-89 hydroxyl group (Fig. 2). 
which concerts with the incr=asing rate of inactivation 
in the ion presence. The reason for this may be a direct 
Ca:" coordination with the tyrosine protein residue. The 
inhibitory Ca"" effect on the enzyme activity has been 
known for many years, but untbrtunately itsmolecular 
mechanism was not understood. It cannot be excluded 
that Tyr-89 incorporation i to the complex with Ca:" 
prevents it from participating in catalysis. 
(iii) The inorganic phosphate, the product of enzy- 
matic pyrophosphate conversion, effectively protects 
the enzyme in the presence of Mn"" when the concentra- 
tion of P~ is sufficient for saturation of the high-affinity 
site (Exp. 12). A similar protective action is known for 
Arg-77 modification [l]. Consequently, Tyr-89 and 
Arg-77 are probably drawn together and located near 
the ph¢' sphate site. 
(iv} The modified PPas¢ possesses an absorption 
spectrum with A..,.~ = 345 am, which is not typical for 
low molecular weight tyrosine derivatives. The hy- 
pochromic displacement by 35 nm indicates the absence 
of ~-electron i teraction between tyrosin¢ and benzofu- 
razane and shows a strict Tyr orientation in the active 
site, 
(v) The PPase amino acid sequence maintains eleven 
Tyr residues, but PPas¢ treatment with benzofarazane 
leads to modification of single Tyr-89. High Tyr reactiv- 
ity demonstrates its increasing nucleophilicity, that is its 
high ability for deprotonation. 
Combined experimental data permit to assume that 
Tyr-89 is strictly fixed at the active site near the Pt 
binding site. The ease of Tyr deprotonization allows for 
the formation of .'m H.bond between the Tyr hydroxyl 
group and the oxygen both of P~ and PP~. Since phos- 
phoric acid. liberated from the substrat¢ is a weaker 
acid than pyrophosphate it can leave the active site only 
after binding of at least else proton. Probably Tyr-89 is 
a donor of this proton. 
The importance of Tyr-89 for the enzyme activity is 
confirmed by recent results on site-directed matagcnesis 
of another enzyme. PPas¢ from E. curl [15]. Unfortu- 
nately, the Tyr role remains undetermined. However. it 
should be noted that in spite of ti~e high homology of 
two PPases from S. cerevisiae and from E. cutL the 
mechanisms of their action are similar but not identical. 
In any case, 7.chloro-4.nltrobcnzofurazane und r con- 
ditions appropriate for the modification of PPase from 
S. cerevisiae does not inhibit PPase from E. coll. 
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